Psilocybin and Psychedelics in Arizona: Pending Legislation
This page tracks the current legal status of psilocybin, psychedelics, and entheogens in Arizona. Status is updated from our legislation sync, with citations to the underlying bills and policy decisions.
Arizona has multiple active psychedelic bills in 2026. HB 2871 by Rep. Justin Wilmeth (R) would fund $5 million in ibogaine clinical trials from the state General Fund (FY2026). HB 2506 (2025) continues advancing psilocybin research. The state also allocated ibogaine research funding in the FY2026 budget, signaling growing bipartisan support.
HB 2871 by Rep. Justin Wilmeth (R) — $5 million for ibogaine clinical trials Funding from state General Fund with private sector matching requirement HB 2506 (2025) continues advancing psilocybin research framework FY2026 budget includes ibogaine research allocation Bipartisan support: Republican-led ibogaine research efforts Focus on veteran mental health and addiction treatment applications
Laws change. Always verify current status with primary sources before acting on this information, especially when traveling across state lines.